Imricor Medical Systems, Inc. (ASX: IMR) | ARBN 633 106 019 400 Gateway Blvd. | Burnsville, Minnesota 55337 USA | +1 952.818.8400 | imricor.com Q2 FY26 RESULTS WEBINAR NOTIFICATION 4 August 2026 – Melbourne, Australia ( 3 August 2026 – Minneapolis, MN United...
Q2 FY26 Results Webinar Notification
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The webinar will take place on the morning of the results release, featuring the Chair and CEO, Steve Wedan, and CFO, Jonathon Gut. This notification serves to inform investors about the upcoming event and the opportunity to submit questions in advance.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Imricor Medical Systems, Inc. on 6ix
Later from Imricor Medical Systems
- Philips Declares Compatibility with Imricor
- Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
- 2026 Q2 Form 10-Q
- 1H 2026 Investor Presentation
- Imricor U.S. Commercial Momentum Accelerates
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems